Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

3.15USD
1:30am IST
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.15
Day's Low
$3.15
Volume
100
Avg. Vol
3,453
52-wk High
$8.48
52-wk Low
$2.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 92.36 -0.835
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.18 34.10
P/E High - Last 5 Yrs. -- 47.73 54.36
P/E Low - Last 5 Yrs. -- 27.38 28.26
Beta -- 1.00 0.99
Price to Sales (TTM) 36.35 6.17 7.99
Price to Book (MRQ) 4.14 3.86 4.39
Price to Tangible Book (MRQ) 33.88 4.17 5.11
Price to Cash Flow (TTM) -- 22.10 24.00
% Owned Institutions -- 0.78 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.81 1.65
Dividend Yield - 5 Year Avg -- 1.48 1.37
Dividend 5 Year Growth Rate -- 6.71 6.79
Payout Ratio(TTM) -- 51.42 47.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 12.94 14.82
Sales (TTM) vs TTM 1 Yr. Ago -- 6.36 8.25
Sales - 5 Yr. Growth Rate -- 8.42 9.51
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.40 17.01 18.20
EPS (TTM) vs TTM 1 Yr. Ago 22.41 -- --
EPS - 5 Yr. Growth Rate -- 5.64 7.10
Capital Spending - 5 Yr. Growth Rate 74.60 6.91 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.53 2.53
Current Ratio (MRQ) 3.80 3.56 3.53
LT Debt to Equity (MRQ) 53.94 11.79 12.82
Total Debt to Equity (MRQ) 54.79 16.39 17.94
Interest Coverage (TTM) -47.14 7.37 14.83

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.67 51.34 50.22
Gross Margin - 5 Yr. Avg. -- 50.56 51.36
EBITD Margin (TTM) -1,232.14 -- --
EBITD - 5 Yr. Avg -- 17.64 16.44
Operating Margin (TTM) -1,242.12 -1.83 -6.57
Operating Margin - 5 Yr. Avg. -- 13.97 11.92
Pre-Tax Margin (TTM) -1,244.30 -2.18 -6.93
Pre-Tax Margin - 5 Yr. Avg. -- 18.91 15.92
Net Profit Margin (TTM) -1,244.87 -5.86 -10.72
Net Profit Margin - 5 Yr. Avg. -- 14.21 11.28
Effective Tax Rate (TTM) -- 20.18 20.52
Effective Tax Rate - 5 Yr. Avg. -- 22.91 24.48

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,011,587,807 871,354,112
Net Income/Employee (TTM) -- 118,320,265 101,932,718
Receivable Turnover (TTM) 5.99 5.63 5.89
Inventory Turnover (TTM) -- 2.60 3.65
Asset Turnover (TTM) 0.06 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.61 10.51 10.21
Return on Assets - 5 Yr. Avg. -- 11.67 11.16
Return on Investment (TTM) -98.11 12.97 12.64
Return on Investment - 5 Yr. Avg. -- 14.78 14.13
Return on Equity (TTM) -144.36 14.15 17.18
Return on Equity - 5 Yr. Avg. -- 15.90 15.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.82%
# of Holders: 3
Total Shares Held: 2,914,062
3 Mo. Net Change: -18,238
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.